Please assess the completion status of the following clinical trial:

Trial Title: Moxonidine in Patients Undergoing Vascular Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* abdominal aortic or peripheral vascular surgery~Exclusion Criteria:~* unstable angina,~* severe symptomatic heart failure (NYHA IV)~* systolic blood pressure at rest \< 100 mmHg~* bradycardia (\<50/min)~* higher grade AV heart block~* creatinine clearance \< 30 ml/min~* pregnancy~* no consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- I (Type: ACTIVE_COMPARATOR): moxonidine group
- II (Type: PLACEBO_COMPARATOR): placebo group

Based on this trial design, predict the completion outcome and termination type (if applicable).